Diligence memo · auto-generated · as of July 2, 2026
Intera Oncology Inc.
Intera Oncology Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Intera Oncology Inc. operates in Pharma, based in WELLESLEY HILLS.
Sub-sector tags: pharma.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Intera Oncology Inc. has raised $3.7M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $2.4M on 2019-03-13.
Most recent recorded round closed around 2021-07-30.
Valuation (modeled)modeled
Provath models Intera Oncology Inc. at approximately $9.0M (range $313K–$53M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.16× the median modeled value of Seed Pharma companies in 2019–2021 (20 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 14 months.
Last raise 4.9 yr ago; this sector typically re-raises about every 16 months.
Silent for over 3× the sector's normal cadence.
The last round was 2.1× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 52% of Pharma peers (310 compared).
Modeled value ranks above 33% of those peers.
Closest niche peers: Zoo Pharma Dynamics Inc., Pharma-Labs Finance LLC, FSD Pharma Inc., Deepbiome Therapeutics, Inc., Pykus Therapeutics, Inc..
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.